- Home
- BPTH vs BDRX Comparison
BPTH vs BDRX Comparison
Compare BPTH & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPTH
- BDRX
- Stock Information
- Founded
- BPTH 2007
- BDRX 2000
- Country
- BPTH United States
- BDRX United Kingdom
- Employees
- BPTH N/A
- BDRX N/A
- Industry
- BPTH Biotechnology: Pharmaceutical Preparations
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- BPTH Health Care
- BDRX Health Care
- Exchange
- BPTH Nasdaq
- BDRX Nasdaq
- Market Cap
- BPTH 5.0M
- BDRX 2.4M
- IPO Year
- BPTH N/A
- BDRX N/A
- Fundamental
- Price
- BPTH $1.09
- BDRX $4.45
- Analyst Decision
- BPTH Strong Buy
- BDRX Strong Buy
- Analyst Count
- BPTH 2
- BDRX 1
- Target Price
- BPTH $30.00
- BDRX $200.00
- AVG Volume (30 Days)
- BPTH 6.2M
- BDRX 24.9K
- Earning Date
- BPTH 11-15-2024
- BDRX 01-17-2025
- Dividend Yield
- BPTH N/A
- BDRX N/A
- EPS Growth
- BPTH N/A
- BDRX N/A
- EPS
- BPTH N/A
- BDRX N/A
- Revenue
- BPTH N/A
- BDRX $104,895.00
- Revenue This Year
- BPTH N/A
- BDRX N/A
- Revenue Next Year
- BPTH N/A
- BDRX N/A
- P/E Ratio
- BPTH N/A
- BDRX N/A
- Revenue Growth
- BPTH N/A
- BDRX N/A
- 52 Week Low
- BPTH $0.59
- BDRX $3.50
- 52 Week High
- BPTH $12.00
- BDRX $74.00
- Technical
- Relative Strength Index (RSI)
- BPTH 54.13
- BDRX 48.88
- Support Level
- BPTH $1.11
- BDRX $3.83
- Resistance Level
- BPTH $1.34
- BDRX $4.73
- Average True Range (ATR)
- BPTH 0.30
- BDRX 0.33
- MACD
- BPTH 0.02
- BDRX 0.07
- Stochastic Oscillator
- BPTH 16.36
- BDRX 69.89
About BPTH Bio-Path Holdings Inc.
Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target-specific protein inhibition for any gene product that is over-expressed in disease. The company's drug candidate, prexigebersen, is in the efficacy portion of Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and combination with decitabine. The other drugs of the company are BP1002, BP1003, BP1001-A, and DNABILIZE.
About BDRX Biodexa Pharmaceuticals plc American Depositary Shs
Biodexa Pharmaceuticals PLC is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.